FREE Shippingto US, AU, UK and EU on all orders over $149


  • New Arrivals
  • Sale
  • Hot items

Keltikan (30 capsules)




Trade name
of Keltikan®

the International unlicensed name
Is not present

the Dosage form

of the Structure One Capsule Capsule contains:
Active agent: cytidine-5 ´-monophosphate disodium salt – 5 mg, uridine 5´ – trisodium of triphosphate, uridine 5 ´-dinatrium of diphosphate, uridine 5´ – monophosphate dinatrium – 3 mg (that corresponds to 1.33 mg of pure uridine)
excipients: citric acid, citrate sodium dihydrate, magnesium stearate, silicon dioxide colloidal (aerosil 200), Mannitolum.
gelatin capsule: ferrous oxide black (E 172), titan dioxide (E 171), indigo carmine (E 132), gelatin.

The description
Solid gelatin capsules (No. 2) with the opaque body of gray color and a lid of blue color. Contents of capsules – white hygroscopic powder.

Pharmacotherapeutic group
Drugs for treatment of diseases of nervous system others. Other drugs for treatment of diseases of nervous system.
The ATX N07XX code

the Pharmacological

Pharmacokinetics Keltikan properties is a combination of two nucleotides – cytidinemonophosphate and uridinemonophosphate. These nucleotides are present at an organism therefore it is not possible to conduct a typical pharmacokinetic research.
The pharmacodynamics
of Keltikan® provides an organism with the phosphatic groups necessary for association of monosaccharides with Keraminums for forming of nervous covers, and the fosfatidny acids making sphingomyelin and glycerophospholipids – the main components of a myelin cover. Thus, the steady trophic effect, fuller maturing and regeneration of axonal nerve fibrils is provided. Therefore inflammation decreases and the sensitivity of the damaged site of an axon is normalized that promotes restoration of axonal transport.

– sciaticas (lumbago, a lyumbalgiya, a lumbar ishialgia)
– a diabetic polyneuropathy
– poluneuritis potatorum
– shingles, a ganglionitis
– inflammation of a trifacial, neuralgia front, trigeminal,
intercostal nerves
– plexites.

The route of administration and doses
of Keltikan® of the capsule accept orally.
Adults: on 1–2 capsules 2 times a day. Келтикан® it is possible to accept to or after meal. The recommended duration of a course of treatment — not less than 10 days. If necessary reception of capsules can be continued for 20 days if the doctor considers necessary it.

Side effects
it was Not described.
Manifestation of allergic reactions, in case of manifestation of any undesirable phenomena is possible, it is necessary to suspend reception and it is obligatory to see a doctor.

– hypersensitivity to drug
– children’s age up to 18 years

Medicinal interactions
it is not established.

The special
instructions Pregnancy and the period of a lactation
Use of drug during pregnancy and a lactation is not contraindicated, but the expediency of reception and a drug dose are established by the doctor, depending on advantage of advantage of use over potential risk for the fruit/child.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous
Keltikan® mechanisms does not influence ability to control of vehicles and performance of work, connected with need of concentration of attention.

The overdose
Due to the hypotoxicity of drug overdose is improbable.

A form of release and packing
On 15 capsules in blister strip packaging from a film of the polivinilkhloridiny and printing aluminum foil varnished.
On the 2nd blister strip packagings together with the instruction for use in the state and Russian languages place in a pack from cardboard.

To Store storage conditions at a temperature not above 30 °C.
To store out of children’s reach!

2 years
not to apply a period of storage after the expiration date specified on packing.

Prescription status
According to the prescription

the Producer Ferrer Internasyonal, S.A., Spain. Provided Nikomed Austria GmbH, Austria


There are no reviews yet.

Be the first to review “Keltikan (30 capsules)”

Your email address will not be published. Required fields are marked *